These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2110224)

  • 1. Oltipraz treatment in experimental schistosomiasis mansoni:VII. Effect of high dose oral therapy on alkaline phosphatase level in livers of infected mice.
    Aboul-Atta AM; Hassan ZA; Awadallah FE; el-Ahl SS; Hamdy BH
    J Egypt Soc Parasitol; 1990 Jun; 20(1):221-30. PubMed ID: 2110224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oltipraz treatment in experimental schistosomiasis mansoni: VI. Effect of high dose oral therapy on alkaline phosphatase level in the intestines of infected mice.
    Aboul-Atta AM; Hassan ZA; Awadallah FE; el-Ahl SS; Hamdy BH
    J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):859-67. PubMed ID: 2507657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oltipraz treatment in experimental schistosomiasis mansoni. II. Effect of high dose oral therapy on worm load and process of copulation in infected mice.
    Aboul-Atta AM; Hassan ZA; el-Ahl SS
    J Egypt Soc Parasitol; 1989 Dec; 19(2):427-36. PubMed ID: 2504822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oltipraz treatment in experimental schistosomiasis mansoni: IV. Histopathological changes in the intestines of infected mice induced by high dose oral therapy.
    Aboul-Atta AM; Zeedan AH
    J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):789-95. PubMed ID: 2507651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oltipraz treatment in experimental schistosomiasis mansoni: V. Histopathological changes in the livers of infected mice induced by high dose oral therapy.
    Aboul-Atta AM; Zeedan AH
    J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):805-14. PubMed ID: 2507652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oltipraz treatment in experimental schistosomiasis mansoni: III. Effect of high dose oral therapy on hepatic shift of worms and tissue bound ova pattern in infected mice.
    Aboul-Atta AM; Hassan ZA; el-Ahl SS
    J Egypt Soc Parasitol; 1989 Dec; 19(2):641-51. PubMed ID: 2504827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prophylactic and curative effect of oltipraz in experimental schistosomiasis mansoni in mice.
    Aboul-Atta AM
    J Egypt Soc Parasitol; 1990 Jun; 20(1):187-95. PubMed ID: 2110222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
    Morsy GH
    J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oltipraz treatment in experimental schistosomiasis mansoni. I. Morphological changes among S. mansoni worms induced by high dose oral therapy in mice.
    Aboul-Atta AM; Hassan ZA; el-Ahl SS
    J Egypt Soc Parasitol; 1989 Jun; 19(1):337-58. PubMed ID: 2496185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental study on the effect of praziquantel and oltipraz on some lysosomal enzymes.
    el-Sharkawy A; el-Toukhy M; Abdel-Rahman SZ; el-Kholy Z; Farag H; el-Zoghby S; Gaber N
    J Trop Med Hyg; 1993 Feb; 96(1):28-34. PubMed ID: 8429571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers.
    Ahmed SA; Gad MZ
    Arzneimittelforschung; 1995 Dec; 45(12):1324-8. PubMed ID: 8595093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field trials with Oltipraz against Schistosoma mansoni in the Gezira Irrigated Area, Sudan.
    Kardaman MW; Fenwick A; el Igail AB; el Tayeb M; Bennett JL; Daffalla AA
    J Trop Med Hyg; 1985 Apr; 88(2):95-100. PubMed ID: 3897560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Schistosoma mansoni infection and treatment on drug metabolizing enzymes.
    Ebeid FA; Seif el-Din SH; Ezzat AR
    Arzneimittelforschung; 2000 Sep; 50(9):867-74. PubMed ID: 11050708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
    William S; Guirguis F; Nessim NG
    Arzneimittelforschung; 2003; 53(7):532-7. PubMed ID: 12918221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of Schistosomiasis mansoni with RP 35972 (Oltipraz). Preliminary results (author's transl)].
    Cerf P; Moyroud J; Coulanges P
    Bull Soc Pathol Exot Filiales; 1982; 75(2):174-8. PubMed ID: 7105289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oltipraz--antischistosomal efficacy in Sudanese infected with Schistosoma mansoni.
    Bella H; Rahim AG; Mustafa MD; Ahmed MA; Wasfi S; Bennett JL
    Am J Trop Med Hyg; 1982 Jul; 31(4):775-8. PubMed ID: 7048948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oral treatment of urinary schistosomiasis in Egyptian patients with 'Oltipraz'.
    Abaza H; El-Kady A; Wasfy E
    Trop Geogr Med; 1984 Jun; 36(2):139-42. PubMed ID: 6474558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
    Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
    Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antischistosomal effects of praziquantel, its alkaline hydrolysis and sun decomposed products on experimentally S. mansoni infected albino mice. (A) Efficacy assessment based on clinicopathological findings.
    Suleiman MI; Akarim EI; Ibrahim KE; Saad AM; Mohammed AE; Ahmed BM; Sulaiman SM
    J Egypt Soc Parasitol; 2004 Apr; 34(1):131-42. PubMed ID: 15143740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic evaluation of oltipraz in human S. mansoni infection].
    de Carvalho SA; Amato Neto V; Zeitune JM; Shikanai-Yasuda MA; Takiguti CK
    Rev Inst Med Trop Sao Paulo; 1986; 28(4):271-7. PubMed ID: 3105039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.